Category: Cancer

Cancer

New AI Test Estimates Individualized Chemotherapy Benefit in Breast Cancer Patients

Using causal artificial intelligence and digital pathology, the test moves beyond population-level averages to predict patient-specific chemotherapy outcomes.

Lunit, CellCarta Partner to Advance AI-Powered Digital Pathology for Companion Diagnostics
Nucleosome Levels Found Elevated in Trauma Patients at Risk for Blood Clots, Mayo Clinic Study Shows
DPYD Testing Gaps Leave Colorectal Cancer Patients at Risk for Severe Drug Toxicity
CSF Liquid Biopsy Delivers 82% Clinical Impact Rate in CNS Lymphoma Cases
Liquid Biopsy Technology Detects Over 95% of Early-Stage Cancers in Blinded Validation Study
Nucleosome Liquid Biopsy Shows Promise for Lung Cancer Risk Stratification
Gene Expression Profile Test Identifies High-Risk Melanoma Patients Missed by Traditional Methods
Largest Lung Nodule Biomarker Validation Study Backs Earlier Cancer Detection
Ultrasensitive ctDNA Test Outperforms Standard Metrics in Predicting Breast Cancer Outcomes After Neoadjuvant Therapy

Cancer

Primerdesign and Origin Sciences Partner to Optimize DNA Extraction from Rectal Mucus for Colorectal Cancer Detection

The collaboration has produced a custom nucleic acid extraction workflow designed to unlock molecular insights from a novel biospecimen and improve diagnostic utility in gut health conditions.

Cancer

Protein Biomarker Tests May Detect Cancer Earlier Than DNA-Based Methods

20/20 BioLabs argues a tiered screening approach—starting with protein-based tests before moving to circulating tumor DNA testing or imaging—could improve early-stage detection and lower costs.

Veracyte Presents 15 Studies on Decipher Cancer Tests at ASCO GU Symposium

Feb 26, 2026 | Prostate

Veracyte will present over 15 studies on its Decipher prostate and bladder cancer tests, including new clinical trial data, at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco.

NeoGenomics Launches PanTracer Pro for Solid Tumor Testing

Feb 26, 2026 | Cancer, Diagnostic Technologies, Molecular Diagnostics

The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.

Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses

Feb 24, 2026 | Cancer, Diagnostic Technologies, Molecular Diagnostics

The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.

ClearNote Health Launches Enhanced Pancreatic Cancer Blood Test

Feb 23, 2026 | Pancreatic

ClearNote Health has launched an enhanced pancreatic cancer test, reporting 82.6% sensitivity and 97.5% specificity in high-risk patients using a multianalyte, multiomic blood-based approach.

Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance

Feb 18, 2026 | Lung Cancer

The NeXT Personal molecular residual disease test can now be used for surveillance of patients with Stage I to III non-small cell lung cancer.

Guardant Health Offers Free Colorectal Cancer Screening Tests Through Community Grant Program

Feb 18, 2026 | Colorectal

Guardant Health will provide up to 100 free Shield blood tests per organization to support colorectal cancer screening events and outreach during Colorectal Cancer Awareness Month in March.

First Ascent Biomedical Opens Cancer Testing Lab in Miami

Feb 17, 2026 | Cancer

The CLIA-certified facility offers functional precision medicine testing that analyzes live tumor cells against FDA-approved therapies within 10 days.

Hims & Hers Adds Multi-Cancer Blood Test to Digital Health Platform

Feb 9, 2026 | Cancer

Hims & Hers Health is now offering GRAIL’s Galleri multi-cancer blood test through its digital health platform, expanding access to screening for more than 50 cancer types, including those lacking established protocols.

Blood Test Detects Early-Stage Cancer Using DNA Methylation Patterns

Feb 9, 2026 | Cancer

Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.

New Test Strip Detects Cancer Biomarkers at Ultra-Low Concentrations

Feb 6, 2026 | Cancer, Molecular Diagnostic Analyzers, Molecular Diagnostics

Researchers at La Trobe University have developed a single-use test strip that detects cancer-related microRNAs in blood plasma at concentrations up to 1,000 times lower than current methods.

Oncologists Cite Test Turnaround Times as Top Challenge Amid Rising Care Complexity

Feb 6, 2026 | Cancer, Diagnostic Technologies, Lab Management

New Labcorp survey of 152 oncologists reveals 89% expect care to become more complex within three years, while digital integration and coverage barriers persist.

Ambry Genetics Expands MAVE Research to PALB2 Gene for Hereditary Cancer Testing

Feb 4, 2026 | Cancer

Ambry Genetics supported a new study evaluating 6,718 PALB2 gene variants using MAVEs, advancing risk assessment for hereditary breast and pancreatic cancer.

GRAIL Submits FDA Application for Multi-Cancer Early Detection Test

Feb 2, 2026 | Cancer

GRAIL has submitted an FDA premarket approval application for its Galleri multi-cancer early detection test, supported by data from more than 25,000 participants in US and UK clinical trials.

Study Shows ctDNA Test Detects Immunotherapy Response Early

Feb 2, 2026 | Cancer

A new study found the assay detected immunotherapy response in advanced cancer patients a median of 23 days after treatment—over five months earlier than imaging.

Valley Diagnostics Licenses Biomarker Technology for Cancer, Disease Detection

Jan 28, 2026 | Cancer

Valley Diagnostics has secured exclusive global rights to develop point-of-care lateral flow tests for prostate cancer, lung cancer, and animal diseases, with product rollout planned for 2026.